Skip to Main content Skip to Navigation
Journal articles

Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Delphine Casabonne 1 Yolanda Benavente 2 Julia Seifert Laura Costas 3 María Armesto María Arestin Caroline Besson 4 Fatemeh Hosnijeh Eric Duell 5 Elisabete Weiderpass 6 Giovanna Masala 7 Rudolf Kaaks 8 Federico Canzian 9 María‐dolores Chirlaque Vittorio Perduca 10 Francesca Mancini Valeria Pala 11 Antonia Trichopoulou 12 Anna Karakatsani 13 Carlo La Vecchia 14 Maria‐jose Sánchez Rosario Tumino 15 Marc Gunter 16 Pilar Amiano 1 Salvatore Panico 17 Carlotta Sacerdote 18 Julie Schmidt Heiner Boeing 19 Matthias Schulze 20 Aurelio Barricarte 1 Elio Riboli 21 Anja Olsen 22 Anne Tjonneland 23 Roel Vermeulen 24 Alexandra Nieters 25 Charles Lawrie Silvia Sanjosé
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-paris.archives-ouvertes.fr/hal-02872360
Contributor : Vittorio Perduca <>
Submitted on : Wednesday, June 17, 2020 - 5:38:21 PM
Last modification on : Saturday, October 3, 2020 - 3:57:46 AM

Identifiers

Collections

Citation

Delphine Casabonne, Yolanda Benavente, Julia Seifert, Laura Costas, María Armesto, et al.. Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. International Journal of Cancer, Wiley, 2020, ⟨10.1002/ijc.32894⟩. ⟨hal-02872360⟩

Share

Metrics

Record views

17